March 28, 2025 Update: Plaintiffs in the GLP-1 drug litigation formally opposed efforts by drug manufacturers to dismiss most claims in the consolidated master complaint
As well as from poor diet and digestion, vitamin B12 deficiencies can also be affected by a genetic condition such as: o Pernicious anaemia o Crohns disease o Treatment with proton-pump inhibitors o Atrophic gastritis o Coeliac disease o Use of antacids (acid is required to release B12 from food) o Gastrointestinal surgery o Use of certain medications o Use of illegal drugs and substances including nitrous oxide
Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor linagliptin: a 4-week multicenter, randomized, double-blind, placebo-controlled phase IIa study in Japanese type 2 diabetes patients
In phase 1b and 2 studies, pharmacokinetic assessments showed a mean elimination half-life of approximately 6 days, supporting once-weekly dosing and stable steady-state exposure after 46 weeks
In summary, breastfeeding confers protection not through a single pathway but through a synergistic interaction of barrier enhancement, microbiome shaping, immune education, and antigenic delay, highlighting its critical role as a modifiable factor in the primary prevention of type 1 diabetes
